NCT07613814

Brief Summary

This study aimed to develop and evaluate a hyperemesis management model through the Vibratory Emesis Massage (VEM) nursing intervention in pregnant women experiencing nausea and vomiting. This quasi-experimental study used a pretest-posttest non-equivalent group design involving intervention and control groups. The intervention was administered at the Pericardium 6 (P6) point using a vibratory massage wristband for 15-20 minutes. The study evaluated the effectiveness of the intervention in reducing the severity of nausea and vomiting among pregnant women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2026

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 10, 2026

Completed
5 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 21, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 29, 2026

Completed
Last Updated

June 2, 2026

Status Verified

May 1, 2026

Enrollment Period

5 days

First QC Date

May 21, 2026

Last Update Submit

May 28, 2026

Conditions

Keywords

Pregnant WomenVibratory Emesis MassageNonpharmacological TherapyP6 AcupressureMaternal Nursing

Outcome Measures

Primary Outcomes (1)

  • Change in the Severity of Nausea and Vomiting Symptoms.

    The frequency and clinical severity of hyperemesis gravidarum are assessed using the researcher-modified Pregnancy Unique Quantification of Emesis (PUQE-24) questionnaire. For clinical macro-level analysis, the continuous index scores are converted into an ordinal scale: Score 1 : Mild category (PUQE index score \<6). Score 2 : Moderate category (PUQE index score 7-12) Score 3 : Severe category (PUQE index score \>13)

    Assessed at baseline (pre-test, prior to receiving the device stimulation) and reassessed at the post-test evaluation phase (following the completion of the assigned therapy sessions).

Secondary Outcomes (2)

  • Device Safety and Treatment Discomfort.

    Assessed continuously from the first intervention session (Day 1) until completion of the intervention period (Day 3), including monitoring during hospital care and home follow-up visits.

  • Maternal Demographic and Baseline Clinical Characteristics.

    Measured once at baseline during the initial participant selection and screening phase.

Study Arms (2)

Vibratory Emesis Massage Group

EXPERIMENTAL

Participants received Vibratory Emesis Massage therapy using a vibratory wristband device applied at the Pericardium 6 (P6) acupoint for approximately 15-20 minutes per session, administered 1-2 times daily in addition to standard nursing care.

Device: Vibratory Emesis Massage

Standard Nursing Care Group

NO INTERVENTION

Participants received standard nursing care for hyperemesis gravidarum without Vibratory Emesis Massage intervention.

Interventions

Participants received Vibratory Emesis Massage therapy using a vibratory wristband device applied at the Pericardium 6 (P6) point for approximately 15-20 minutes per session to reduce nausea and vomiting during pregnancy.

Also known as: MVE Wristband Therapy
Vibratory Emesis Massage Group

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsThis study evaluates a nursing intervention designed specifically to manage hyperemesis gravidarum, a medical condition that occurs exclusively during pregnancy. Therefore, eligibility is restricted to female participants.
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnant women diagnosed with emesis gravidarum or hyperemesis gravidarum.
  • Gestational age within the first, second, or third trimester (with a focus on those experiencing active nausea and vomiting symptoms).
  • Aged between 18 and 45 years.
  • Admitted to or receiving care at Prof. Dr. Chairuddin Panusunan Lubis Hospital, University of North Sumatra.
  • Willing to participate in the study and capable of providing written informed consent.

You may not qualify if:

  • Pregnant women with severe medical complications unrelated to hyperemesis (e.g., severe cardiovascular disease, active skin infections, or open wounds at the Pericardium 6 / P6 acupoint area on the wrist).
  • Patients receiving concurrent alternative non-pharmacological therapies for nausea and vomiting that could confound the study results.
  • Patients who are unable to complete the assigned 15-to-20-minute Vibratory Emesis Massage (MVE) sessions due to acute physical or cognitive distress.
  • Participants who choose to withdraw from the hospital treatment or study protocol before the post-test evaluation is completed.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prof. Dr. Chairuddin Panusunan Lubis Hospital, University of North Sumatra

Medan, North Sumatra, 20155, Indonesia

Location

Related Links

MeSH Terms

Conditions

Hyperemesis Gravidarum

Condition Hierarchy (Ancestors)

Morning SicknessPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesVomitingSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Siti Saidah Nasution, S.Kp., M.Kep., Sp.Mat

    Universitas Sumatera Utara

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were assigned into intervention and control groups using a quasi-experimental pretest-posttest non-equivalent group design. The intervention group received Vibratory Emesis Massage therapy, while the control group received standard nursing care.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

May 21, 2026

First Posted

May 29, 2026

Study Start

April 10, 2026

Primary Completion

April 15, 2026

Study Completion

April 15, 2026

Last Updated

June 2, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

The individual participant data will not be publicly shared to protect the confidentiality and privacy of the pregnant women who participated in this study, in accordance with the ethical approval and informed consent signed by the participants

Locations